Assessment Questions: The Great Debate: Unpacking the Controversy of GLP-1 Agonists – Pharmacy & Acute Care University

Skip to content

ACPE Accredited** Pharm So Hard Ambulatory Care Podcast Episodes The Great Debate: Unpacking the Controversy of GLP-1 Agonists Assessment Questions: The Great Debate: Unpacking the Controversy of GLP-1 Agonists

Time limit: 0

Quiz Summary

0 of 10 Questions completed

Questions:

Information

You have already completed the quiz before. Hence you can not start it again.

Quiz is loading…

You must sign in or sign up to start the quiz.

You must first complete the following:

Results

Quiz complete. Results are being recorded.

Results

0 of 10 Questions answered correctly

Your time:

Time has elapsed

You have reached 0 of 0 point(s), (0)

Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)

Categories

Not categorized 0%

1
2
3
4
5
6
7
8
9
10

Current
Review
Answered
Correct
Incorrect

Question 1 of 10

1. Question
What is a major concern regarding the role of social media in GLP-1 medication use?
- A) It helps spread accurate medical information to the public
- B) It prevents misinformation from influencing patient decisions
- C) It contributes to misinformation, leading to inappropriate use of GLP-1s
- D) It increases physician awareness of GLP-1 receptor agonists
Correct

Incorrect
Question 2 of 10

2. Question
Which celebrity’s endorsement has influenced public perceptions of GLP-1 receptor agonists?
- A) LeBron James
- B) Oprah Winfrey
- C) Joe Rogan
- D) Taylor Swift
Correct

Incorrect
Question 3 of 10

3. Question
What is one of the main reasons for the GLP-1 shortage discussed in the episode?
- A) Decreased patient interest
- B) Insurance restrictions reducing demand
- C) Increased off-label use for cosmetic weight loss
- D) FDA banning GLP-1 receptor agonists
Correct

Incorrect
Question 4 of 10

4. Question
Why are GLP-1 receptor agonists not recommended as a “quick fix” for weight loss?
- A) They work immediately and require no lifestyle changes
- B) Weight regain is likely if the medication is stopped
- C) They prevent all obesity-related comorbidities permanently
- D) There are no long-term studies on their effects
Correct

Incorrect
Question 5 of 10

5. Question
What was a major concern regarding compounded GLP-1 receptor agonists discussed in the episode?
- A) They are more effective than FDA-approved versions
- B) They are manufactured under strict FDA regulations
- C) They may contain unverified ingredients and unsafe formulations
- D) They are the preferred treatment for type 2 diabetes
Correct

Incorrect
Question 6 of 10

6. Question
What regulatory action has been taken against online pharmacies selling compounded GLP-1s?
- A) They have been fully legalized by the FDA
- B) Eli Lilly and Novo Nordisk have filed lawsuits against unauthorized sellers
- C) The DEA has classified GLP-1s as controlled substances
- D) The FTC has promoted online GLP-1 sales
Correct

Incorrect
Question 7 of 10

7. Question
Why is the use of GLP-1s in patients with a history of eating disorders controversial?
- A) It has been proven to prevent eating disorders
- B) GLP-1s are required for patients with eating disorders
- C) They may trigger disordered eating patterns
- D) Eating disorders improve with GLP-1 therapy
Correct

Incorrect
Question 8 of 10

8. Question
What was a major concern about GLP-1 supply chain issues?
- A) Patients with diabetes and obesity struggle to access medications
- B) The price has dropped too low
- C) There is an excess of GLP-1 supply worldwide
- D) The medications have been banned in some countries
Correct

Incorrect
Question 9 of 10

9. Question
What potential adverse effect of GLP-1 receptor agonists was highlighted in the episode?
- A) Increased risk of thyroid tumors
- B) Elevated blood pressure
- C) Liver toxicity
- D) Hair loss
Correct

Incorrect
Question 10 of 10

10. Question
How do GLP-1 receptor agonists aid in weight loss, as discussed in the episode?
- A) By increasing metabolic rate
- B) By suppressing appetite and slowing gastric emptying
- C) By inhibiting fat absorption in the intestines
- D) By increasing energy expenditure through thermogenesis
Correct

Incorrect

Pharmacy & Acute Care University, Proudly powered by WordPress. Privacy Policy

Login

Accessing this course requires a login. Please enter your credentials below!

Username or Email Address

Password

Remember Me

Lost Your Password?

Register

Don't have an account? Register one!

Register an Account

Username

Email

Registration confirmation will be emailed to you.